Загрузка...
Pharmacokinetics of Zanamivir following Intravenous Administration to Subjects with and without Renal Impairment
Intravenous zanamivir is in clinical development for the treatment of influenza in hospitalized patients, many of whom have renal impairment. This open-label study evaluated zanamivir pharmacokinetics and clinical safety following a single 100-mg intravenous infusion dose in subjects with impaired r...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
American Society for Microbiology
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3697365/ https://ncbi.nlm.nih.gov/pubmed/23587959 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02330-12 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|